Semaglutide plus cagrillentide combination

Rita describes the combo trial showing ~20% loss at 68 weeks, outperforming either drug alone.

Play episode from 02:52

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!